Singapore-based Bioveda Ventures, San Jose, Calif.-based Fenox Venture Capital, Rochester, Minn.-based Mayo Clinic and Stanford (Calif.) StartX also participated in the round.
Sensely’s technology is used for patient engagement and chronic disease monitoring.
“This funding will accelerate Sensely’s mission to provide efficient and affordable care to people around the world utilizing artificial intelligence and machine tools,” said Sensely Founder and CEO Adam Odessky. “The capital raised will allow us to serve our clinicians and patients much better as well as expand our presence in the U.S., U.K. and international markets.”
More articles on health IT:
January averaged 1 data breach per day
Cyber Threat Alliance appoints president, expands membership
These tech jobs have the most year-over-year growth
